Juvenescence

Congratulations to #longevity company Juvenescence for recent fundraise of $76 million !! https://t.co/3AqY5PhRPh

@srqstockpicker @deonsi So Juve goes around touting GDF-15 & they get $75M thrown at them in Series B-1 (they’ve raised 6 rounds which means total capital raised lifetime is around $110-160), and it’s probably at a $250M-500M valuation? Meanwhile $LPTX mgmt can’t get its head out of its ass & $15M val.

Juvenescence raises $76 million in first-close of Series B-1 round https://t.co/SfdJkjh8qJ

$76M Secured: Juvenescence & M42 Unite to Supercharge AI-Driven Drug Discovery! Ramsey-based Juvenescence Ltd., a clinical-stage biotech focused on age-related diseases, has raised $76 million in Series B-1 financing led by Abu Dhabi’s M42 — marking a bold leap forward in https://t.co/queGZCdkmb

🏢 Juvenescence 📍 Ramsey, United Kingdom 🏗️ Healthcare & Life Sciences 💰 $76.0M Series B-1 🤝 Investors: M42 🔗 https://t.co/lMpEohhNKX 📝 Juvenescence Limited, a clinical-stage AI-enabled biotech company based in Ramsey, UK, has successfully raised $76 million in the first